Position in AMGN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$2,544,979
-$119,932 QoQ
Shares Held
7,028
-7.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.51%
of 13F equity value
Holder Rank
#1,141
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EADS & HEALD WEALTH MANAGEMENT holds $8,527,198 across 7 Drug Manufacturers - General names. AMGN ranks #1 (29.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
This page
|
7,028 | $2,544,979 | |
| 2 | JNJ |
Johnson & Johnson
|
8,955 | $2,274,301 | |
| 3 | LLY |
ELI LILLY & Co
|
1,461 | $1,752,367 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
18,330 | $1,056,174 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
3,532 | $446,232 | |
| 6 | BIIB |
Biogen Inc.
|
1,081 | $233,560 | |
| 7 | PFE |
Pfizer Inc
|
9,119 | $219,585 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,544,979 | 7,028 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $2,664,911 | 7,574 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $2,524,214 | 7,712 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $2,178,866 | 7,721 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $2,155,221 | 7,719 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $2,432,582 | 7,808 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $2,080,167 | 7,981 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $2,644,699 | 8,208 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $2,716,752 | 8,695 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $2,484,103 | 8,737 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $2,674,553 | 9,286 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $2,533,063 | 9,425 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $2,114,518 | 9,524 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $2,407,346 | 9,958 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $2,536,839 | 9,659 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $2,185,478 | 9,696 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $2,348,574 | 9,653 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $2,361,614 | 9,766 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $2,208,080 | 9,815 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $2,038,462 | 9,586 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $2,270,043 | 9,313 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $2,340,804 | 9,408 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $2,171,364 | 9,444 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $2,390,883 | 9,407 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $2,390,441 | 10,135 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $2,090,349 | 10,311 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||